Refractory Bladder Urothelial Carcinoma
3 clinical trials · Condition
◉ Watch Refractory Bladder Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers (NCT07087860) | Mayo Clinic | 2025-08-01 |
| Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib (NCT05052372) | xCures | 2021-11-21 |
| Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer (NCT04579224) | National Cancer Institute (NCI) | 2021-06-28 |
Track Refractory Bladder Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.